- Trials with a EudraCT protocol (2,620)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (122)
2,620 result(s) found for: Compliance.
Displaying page 8 of 131.
EudraCT Number: 2008-004273-18 | Sponsor Protocol Number: | Start Date*: 2008-11-03 | |||||||||||
Sponsor Name:Institut Bergonié | |||||||||||||
Full Title: A phase II trial to assess the efficacy of efavirenz as second-line monotherapy for the treatment of advanced pancreatic adenocarcinomas. | |||||||||||||
Medical condition: Advanced pancreatic adenocarcinomas who escaped to a first ligne chemotherapy treatment based on Gemcitabine. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005184-13 | Sponsor Protocol Number: 50129 | Start Date*: 2017-11-29 |
Sponsor Name:MEDIOLANUM FARMACEUTICI S.P.A. | ||
Full Title: METRO STUDY - MESOGLYCAN VERSUS PLACEBO IN SECONDARY PREVENTION OF SURFACE VEIN THROMBOSIS | ||
Medical condition: patients with SVT of the lower limbs that have completed the acute phase treatment cycle | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-004131-84 | Sponsor Protocol Number: ChronIA001 | Start Date*: 2022-02-14 | ||||||||||||||||
Sponsor Name:Erasmus Medical Center | ||||||||||||||||||
Full Title: Chronotherapy in Inflammatory Arthritis (ChronIA trial): a randomized controlled trial comparing the effectiveness of morning and evening dosing of tofacitinib extended-release | ||||||||||||||||||
Medical condition: Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000927-38 | Sponsor Protocol Number: PLATONEv1.0.2020 | Start Date*: 2021-07-27 | |||||||||||
Sponsor Name:AIGO - Associazione Italiana Gastroenterologi ed Endoscopisti DIgestivi Ospedalieri | |||||||||||||
Full Title: Bowel preparation with either novel 1L PEG+Asc or 2L PEG+Asc solution: a multicenter, randomized study in elderly outpatients: the PLATONE Study. | |||||||||||||
Medical condition: Bowel preparation for diagnostic / operative colonscopy in outpatient | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005065-31 | Sponsor Protocol Number: 9769 | Start Date*: 2017-05-09 |
Sponsor Name:University hospital of Montpellier | ||
Full Title: Comparison of preoperative hemoglobin after administration of epoetin alpha associated with oral martial supplementation vs intraveinous martial supplementation before craniosynostosis in children | ||
Medical condition: Craniosynostosis | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001721-26 | Sponsor Protocol Number: B9R-EW-GDFC(a) | Start Date*: 2006-09-25 |
Sponsor Name:UAB “Eli Lilly Lietuva” | ||
Full Title: The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS) | ||
Medical condition: Short Stature | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: LT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001148-31 | Sponsor Protocol Number: | Start Date*: 2011-09-13 |
Sponsor Name:Imperial College London | ||
Full Title: A pilot clinical trial with the iron chelator Deferiprone in Parkinson's disease | ||
Medical condition: Parkinson's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004762-33 | Sponsor Protocol Number: MOPAD | Start Date*: 2019-12-19 |
Sponsor Name:InfectoPharm Arzneimittel und Consilium GmbH | ||
Full Title: Prospektive, randomisierte, Nicht-Behandlungs-kontrollierte, Untersucher-verblindete, Multizenter-Studie zur Prophylaxe von frühkindlichen Symptomen der Atopischen Dermatitis bei Hochrisiko-Kindern... | ||
Medical condition: Prävention der frühkindlichen Symptome der Atopischen Dermatitis bei Hochrisiko-Kindern | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002174-22 | Sponsor Protocol Number: Avifibro | Start Date*: 2006-11-08 |
Sponsor Name:Mondobiotech Laboratories Anstalt | ||
Full Title: Influence of inhaled Aviptadil on CCL18 serum concentrations in patients with pulmonary fibrosis | ||
Medical condition: Pulmonary Fibrosis categorized as UIP or NSIP | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000767-20 | Sponsor Protocol Number: 2005-09-20 | Start Date*: 2008-03-13 |
Sponsor Name:Koagulationscentrum UMAS | ||
Full Title: Daglig profylax vid svår hemofili | ||
Medical condition: Hemofili | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016446-50 | Sponsor Protocol Number: - | Start Date*: 2010-04-19 | |||||||||||
Sponsor Name:Maastricht University - CAPHRI School for Public Health and Primary Care | |||||||||||||
Full Title: Helping more smokers to quit by combining varenicline with counselling for smoking cessation. The COVACO randomized controlled trial. | |||||||||||||
Medical condition: Smoking: Subjects must be daily smokers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001990-25 | Sponsor Protocol Number: BO1 | Start Date*: 2004-09-06 |
Sponsor Name:Bo Söderpalm | ||
Full Title: Hur påverkar Remeron alkoholkonsumtionen? How will Remeron influence alcohol consumption in high consumers? | ||
Medical condition: The subjects in the study will be recruited via an advertisment and will not have a diagnos. We will include males with high consumption of alcohol, defines as 400 grams or more of 100% alcohol per... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004231-53 | Sponsor Protocol Number: 506067 | Start Date*: 2004-12-22 |
Sponsor Name:Royal Devon and Exeter NHS Foundation Trust | ||
Full Title: The Effect Of Antihypertensive Treatment With Lisinopril and Labetalol on Baroreflex Sensitivity in Stroke | ||
Medical condition: Stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-011423-31 | Sponsor Protocol Number: noneX | Start Date*: 2009-09-04 | |||||||||||
Sponsor Name:CENTRE JEAN PERRIN | |||||||||||||
Full Title: Essai pilote de phase II évaluant l'association Taxotère® plus curcumine en première ligne de traitement des cancers de la prostate métastatiques hormono-résistants | |||||||||||||
Medical condition: cancers de la prostate métastatiques hormono-résistants | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017664-16 | Sponsor Protocol Number: 200905-02 | Start Date*: 2010-03-22 |
Sponsor Name:BIOTRONIK France | ||
Full Title: GIANT Study - Genotyping Infarct patients to Adjust and Normalize Thienopyridine treatment | ||
Medical condition: The GIANT trial is dedicated to STEMI patients being treated by a primary PCI (with stent implantation) within the 24 hours following the first pain. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000329-78 | Sponsor Protocol Number: PMF603-PA1/06 | Start Date*: 2006-06-14 | |||||||||||
Sponsor Name:PROMEFARM | |||||||||||||
Full Title: Naburen enema for prevention of radiation proctitis. A multicentre randomised placebo-controlled dose-finding phase II study to evaluate efficacy, tolerability, acceptability and compliance with en... | |||||||||||||
Medical condition: Radiation Proctitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001705-26 | Sponsor Protocol Number: CYD-GER-0401 | Start Date*: 2005-09-21 |
Sponsor Name:Spirig Pharma AG | ||
Full Title: Efficacy and safety of topically applied cyclodextrin gel (Spirig Pharma) in the treatment of recurrent genital herpes simplex virus infections: a randomised, double-blind, placebo-controlled, mult... | ||
Medical condition: Genito-anal herpes simplex infections | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003244-11 | Sponsor Protocol Number: RC 20/07 | Start Date*: 2007-02-27 | |||||||||||
Sponsor Name:ISTITUTO PER L`INFANZIA BURLO GAROFOLO | |||||||||||||
Full Title: Evaluation of efficacy, acceptability and safety of two different solutions of PEG for colonoscopy in children: a prospective randomized trial. | |||||||||||||
Medical condition: Children undergoing colonoscopy. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003047-22 | Sponsor Protocol Number: RB-UK-11-0017 | Start Date*: 2012-01-12 | |||||||||||
Sponsor Name:Reckitt Benckiser Pharmaceuticals | |||||||||||||
Full Title: A Randomised, Double-Blind, Double-Dummy, Active-Drug-Controlled, Parallel-Group, Multicentre Acceptability and Safety Study of the Transfer from Subutex®/Suboxone® to RBP-6300 in Opioid-Dependent ... | |||||||||||||
Medical condition: Maintenance/substitution agent for the treatment of opioid dependence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) SE (Completed) CZ (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000985-12 | Sponsor Protocol Number: 1719-B | Start Date*: 2018-11-26 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Near-infrared fluorescence imaging in kidney transplantations using ZW800-1 for perfusion assessment: a pilot study | ||
Medical condition: Patients undergoing a living-donor kidney transplantation (living kidney donor and kidney recipient) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
